Clinical Trials
50 trialsSANGUINE
JaxBio Ltd
INTHEMA
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate
BTG International Inc.
SYS01
University Hospital Tuebingen
ACC Platform
Fondazione del Piemonte per l'Oncologia
Is Ibrutinib-related Atrial Fibrillation Dose Dependent
University Hospital, Caen
Prognostic Value of "CD200" in Hematological Malignancies. Hematological Malignancies Comprise a Group of Malignant Clonal Disorders Arising From the Hematopoietic Tissues , Including Leukemia , Multiple Myeloma , and They Have a High Morbidity and Mortality
Sohag University
COVIDVAC OH
Assistance Publique - Hôpitaux de Paris
Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201)
University of British Columbia
Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study
University of British Columbia
IRAF-ABLATION Study: a Multicenter International Retrospective Cohort of Patients With BTK Inhibitors-related AF Treated by Catheter Ablation
University Hospital, Caen
Correlation Between Gut Microbiota and Clinical Response to CAR-T Treatment for Hematological Malignancies
The First Affiliated Hospital of Soochow University
The Optimization of Haploidentical Hematopoietic Stem Cell Transplantation
Peking University People's Hospital
Oral Complications in Hematological Malignancies
Assiut University
PBT
Aga Khan University
QUALITOP - Monitoring Multidimensional Aspects of QUAlity of Life After Cancer ImmunoTherapy, an Open Smart Digital Platform for Personalized Prevention and Patient Management
Hospices Civils de Lyon
COVID19-hematological Malignancies: the Italian Hematology Alliance
Ospedale di Circolo - Fondazione Macchi
The Association of Microbiota Composition With cGVHD After Allo-HSCT
First Affiliated Hospital of Zhejiang University
KTcCHO
Centre Hospitalier Alpes Leman
Symptom Clusters in Hong Kong Chinese Children With Blood Cancer
The Hong Kong Polytechnic University
Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune System
National and Kapodistrian University of Athens
Determination of Sarcopenia Risk and Related Factors in Pediatric Oncological Patients
Trakya University
THERMAL
Malaghan Institute of Medical Research
Analysis of Immunogenicity, Safety and Efficacy of COVID-19 Vaccines in Immunosuppressed Individuals
Vilnius University
A Real-world Study of Herombopag in the Treatment of Thrombocytopenia Related Diseases in Henan Province
Henan Cancer Hospital
Immunogenicity of Covid-19 Vaccination for Patients With Hematological Malignancies
Ospedale di Circolo - Fondazione Macchi
An Online-platform to Improve Patient-centered Care During the COVID-19 Pandemic: a GIMEMA Surveillance Program in Hematologic Malignancies
Gruppo Italiano Malattie EMatologiche dell'Adulto
BIMI
Centre Hospitalier Universitaire Vaudois
Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic Malignancy
Dokuz Eylul University
B-REC
Assistance Publique - Hôpitaux de Paris
MADESIO
Jules Bordet Institute
MATTER
Maastricht University Medical Center
The Influence of CYP2C19 Polymorphisms on the Safety and Efficacy of Voriconazole
Dokuz Eylul University
ADN-CO
Institut Paoli-Calmettes
ONCO-AGING
University of Eastern Piedmont
SPIRIHEMATO
University Hospital, Limoges
CAR-T Cellular Therapy for B Cell Malignancies Involved in CNS
Zhejiang University
ChimioAge
Assistance Publique Hopitaux De Marseille
MAHM
University Hospital, Strasbourg, France
Economic Evaluation of Innovative Molecular Analyses in Onco-haematology
Assistance Publique - Hôpitaux de Paris
OXYPAL
Poitiers University Hospital
CAPRI
Gustave Roussy, Cancer Campus, Grand Paris
Multidisciplinary Follow-up of Patients Treated for Malignant Hematological Disease
Aalborg University Hospital
Observational Study of the Combination of Post-transplant High Dose Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Acute Graft-versus-Host Disease in Patients Eligible to Allogeneic Hematopoietic Stem Cell Transplant
Fondazione del Piemonte per l'Oncologia
RELab1
University of Pavia
A Randomized Multicenter Study to Compare Two Types of Transplant in Adult Patients With Hematologic Malignancies
Instituto de Investigacion Sanitaria La Fe
Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic Analysis
Rhode Island Hospital
Biomarker Research for Personalized Medicine
Inje University
HPDSC
Celgene
Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes
Community Cancer Care